Furman P A
Curr Eye Res. 1987 Jan;6(1):213-9. doi: 10.3109/02713688709020093.
The following paper is intended to review those nucleoside analogs currently licensed for the treatment of herpetic diseases. Potentially efficacious congeners also will be considered. The mechanism of action, preclinical and clinical efficacy, and the problems associated with the use of each nucleoside analog will be described.
以下论文旨在综述目前已获许可用于治疗疱疹性疾病的那些核苷类似物。也将考虑具有潜在疗效的同类物。将描述每种核苷类似物的作用机制、临床前和临床疗效以及使用中相关的问题。
